Evidence map›Paper›PMID 34943433›Full record

ArticleDiagnostics (Basel, Switzerland)2021

Usefulness of Preoperative High Systemic Immune-Inflammation Index as a Prognostic Biomarker in Patients Who Undergo Radical Cystectomy for Bladder Cancer: Multicenter Analysis.

Shimpei Yamashita, Yuya Iwahashi, Haruka Miyai, Nagahide Matsumura, Keizo Hagino, Kazuro Kikkawa, Yasuo Kohjimoto, Isao Hara

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 9 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 9 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shimpei YamashitaDepartment of Urology, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-0012, Japan.
Yuya IwahashiDepartment of Urology, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-0012, Japan.
Haruka MiyaiDepartment of Urology, Rinku General Medical Center, 2-23 Rinkuoraikita, Izumisano, Osaka 598-8577, Japan.
Nagahide MatsumuraDepartment of Urology, Kinan Hospital, 46-70 Shinjyo, Tanabe, Wakayama 646-8588, Japan.
Keizo HaginoDepartment of Urology, Rinku General Medical Center, 2-23 Rinkuoraikita, Izumisano, Osaka 598-8577, Japan.
Kazuro KikkawaDepartment of Urology, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-0012, Japan.
Yasuo KohjimotoDepartment of Urology, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-0012, Japan.
Isao HaraDepartment of Urology, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-0012, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evidence of the prognostic value of pretreatment systemic immune-inflammation index (SII) after radical cystectomy (RC) for bladder cancer is limited. This study aims to assess the association between preoperative SII and prognosis after RC for bladder cancer. In this multicenter retrospective study, we calculated preoperative SII as well as the neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) in 237 patients who underwent RC for bladder cancer between March 2009 and March 2018. Patients were classified into high SII and low SII groups by using the optimal cutoff value (438 × 10

Indexed as

bladder cancercystectomyinflammationprognosissystemic immune-inflammation index

Identifiers

PMID34943433
PMCPMC8700357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.